Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2025-11-06 00:00:00 ET · period of report 2025-11-05 · accession 0001104659-25-107423 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-06 | 2025-11-05 | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $5.72 | +5,000 | 3.53M | +0.1% | +$28.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-05 | P | A | 5,000 | $5.72 | 3,525,924 | D | — | — | (F1) Includes 676,759 shares of restricted stock. |